Filtering by content type: Press Release
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Boehringer Ingelheim’s $13.53 billion asset swap with Paris-based Sanofi would likely be anticompetitive.
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Abbott Laboratories’ $25 billion acquisition of St. Jude Medical, Inc. would likely be anticompetitive.
Federal Trade Commission Acting Chairman Maureen K. Ohlhausen announced today that she has appointed Abbott (Tad) Lipsky, a partner at the law firm of Latham & Watkins LLP, to be the Acting Director of the FTC’s Bureau of Competition, effective March 6, 2017.
Energy infrastructure companies Enbridge Inc. and Spectra Energy Corp have agreed to settle Federal Trade Commission charges that the proposed merger of Enbridge and Spectra likely would harm competition in the market for pipeline transportation of natural gas in three production areas off the...
The Federal Trade Commission is accepting public comments on an application from SuperValu Inc. to sell one of two supermarkets it bought when Safeway and Albertsons merged in 2015 and were required by the agency to divest 168 stores.
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Bausch + Lomb parent company Valeant Pharmaceuticals International, Inc. illegally acquired Paragon Holdings I, Inc.
The Federal Trade Commission filed a complaint in federal district court charging Shire ViroPharma Inc. (“ViroPharma”) with violating the antitrust laws by abusing government processes to delay generic competition to its branded prescription drug, Vancocin HCl Capsules. The complaint alleges that...
A new Federal Trade Commission report, The FTC’s Merger Remedies 2006-2012: A Report of the Bureaus of Competition and Economics, finds that the agency’s process for maintaining competition when companies merge is generally effective.
The Federal Trade Commission has refiled a complaint and filed a proposed stipulated order in federal court to resolve charges that Endo Pharmaceuticals Inc.
For 2017, the size-of-transaction threshold for reporting proposed mergers and acquisitions under Section 7A of the Clayton Act will increase from $78.2 million to $80.8 million. The new 2017 thresholds under Section 8 of the Act that trigger prohibitions on certain interlocking memberships on...
OFTACOOP, a Puerto Rico ophthalmologist cooperative, has agreed to settle Federal Trade Commission charges that its actions harmed competition.
The complaint charges that OFTACOOP – also known as Cooperativa de Médico Oftalmólogos de Puerto Rico – unlawfully orchestrated an agreement among...
Mallinckrodt ARD Inc., formerly known as Questcor Pharmaceuticals, Inc., and its parent company, Mallinckrodt plc, have agreed to pay $100 million to settle Federal Trade Commission charges that they violated the antitrust laws when Questcor acquired the rights to a drug that threatened its...
The Federal Trade Commission filed a complaint in federal district court charging Qualcomm Inc. with using anticompetitive tactics to maintain its monopoly in the supply of a key semiconductor device used in cell phones and other consumer products.
Hedge fund founder Ahmet H. Okumus has agreed to pay $180,000 in civil penalties to resolve Federal Trade Commission allegations that he violated the Hart-Scott-Rodino Act by failing to report his purchases of voting securities in the internet services company Web.com Group Inc.
The Federal Trade Commission staff submitted a supplemental comment and analysis to the Virginia Department of Health that opposes issuing a letter authorizing a cooperative agreement to Mountain States Health Alliance and Wellmont Health System.
The Federal Trade Commission and the Department of Justice issued today updated Antitrust Guidelines for the Licensing of Intellectual Property that explain how the federal antitrust agencies evaluate licensing and related activities involving patents, copyrights, trade secrets, and know-how.
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that CentraCare’s acquisition of St. Cloud Medical Group, also known as SCMG, would be anticompetitive.
The Federal Trade Commission staff submitted a supplemental comment and analysis to the Tennessee Department of Health that opposes issuing a certificate of public advantage, or COPA, to Mountain States Health Alliance and Wellmont Health System.
The Federal Trade Commission announced today that it is hosting a workshop in Washington, DC on April 18, 2017, to examine competition, innovation, and consumer protection issues raised by hearing health and technology, particularly hearing aids and devices with similar functions and features.
German pharmaceutical company Boehringer Ingelheim has agreed to divest five types of animal health products in the United States in order to settle FTC charges that its proposed asset swap with Paris-based Sanofi would likely be anticompetitive.